SSB
CRSP icon

Sandy Spring Bank’s CRISPR Therapeutics CRSP Stock Holding History

Sandy Spring Bank’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$19.8K Buy
582
+20
+4% +$848 ﹤0.01% 737
2024
Q4 		$22.1K Sell
562
-930
-62% -$43.9K ﹤0.01% 732
2024
Q3 		$70.1K Hold
1,492
– – ﹤0.01% 525
2024
Q2 		$80.6K Hold
1,492
– – ﹤0.01% 493
2024
Q1 		$102K Buy
1,492
+110
+8% +$7.88K ﹤0.01% 463
2023
Q4 		$86.5K Hold
1,382
– – ﹤0.01% 467
2023
Q3 		$62.7K Hold
1,382
– – ﹤0.01% 505
2023
Q2 		$77.6K Hold
1,382
– – ﹤0.01% 463
2023
Q1 		$62.5K Hold
1,382
– – ﹤0.01% 497
2022
Q4 		$56.2K Sell
1,382
-42
-3% -$2.23K ﹤0.01% 511
2022
Q3 		$93K Sell
1,424
-15
-1% -$1.09K 0.01% 422
2022
Q2 		$87K Hold
1,439
– – 0.01% 433
2022
Q1 		$90K Hold
1,439
– – ﹤0.01% 432
2021
Q4 		$109K Hold
1,439
– – 0.01% 427
2021
Q3 		$161K Hold
1,439
– – 0.01% 354
2021
Q2 		$233K Buy
1,439
+300
+26% +$36.5K 0.01% 322
2021
Q1 		$139K Buy
1,139
+106
+10% +$16K 0.01% 355
2020
Q4 		$158K Hold
1,033
– – 0.01% 335
2020
Q3 		$86K Sell
1,033
-20
-2% -$1.77K 0.01% 384
2020
Q2 		$77K Buy
1,053
+121
+13% +$7.08K 0.01% 390
2020
Q1 		$40K Buy
+932
New +$48.1K ﹤0.01% 472

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sandy Spring Bank's CRSP Position: Q1 2025 in Review

Sandy Spring Bank increased its CRISPR Therapeutics (CRSP) stake by 3.6% in Q1 2025, buying an estimated $848 and bringing the position to 582 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Sandy Spring Bank first reported a position in CRSP in Q1 2020 and has held it in 21 quarters since. The position peaked at $233K in Q2 2021. 396 funds tracked by Wall St. Rank hold CRSP as of Q1 2025.

  • Sandy Spring Bank held 582 shares of CRISPR Therapeutics worth $19.8K as of Q1 2025.
  • Sandy Spring Bank bought 20 CRISPR Therapeutics shares in Q1 2025, an estimated $848.
  • CRISPR Therapeutics made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #737 holding.
  • Sandy Spring Bank first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • Sandy Spring Bank's CRISPR Therapeutics position peaked at $233K in Q2 2021.
  • 396 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.